These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36565202)

  • 21. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
    Alam M; Dokainish H; Lakkis N
    J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety.
    Kashtanov MG; Rzhannikova AD; Chernyshev SD; Kardapoltsev LV; Idov EM; Berdnikov SV; Kochmasheva VV
    Catheter Cardiovasc Interv; 2020 May; 95(6):1212-1218. PubMed ID: 31566892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocardial septal ablation for hypertrophic obstructive cardiomyopathy.
    Aksu T; Güler TE; Yalın K; Gölcük ŞE; Özcan KS
    Turk Kardiyol Dern Ars; 2017 Jan; 45(1):67-72. PubMed ID: 28106021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of Influenza-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death by Race and Ethnicity in the United States From 2009 to 2019.
    O'Halloran AC; Holstein R; Cummings C; Daily Kirley P; Alden NB; Yousey-Hindes K; Anderson EJ; Ryan P; Kim S; Lynfield R; McMullen C; Bennett NM; Spina N; Billing LM; Sutton M; Schaffner W; Talbot HK; Price A; Fry AM; Reed C; Garg S
    JAMA Netw Open; 2021 Aug; 4(8):e2121880. PubMed ID: 34427679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex and Race Disparities in Hypertrophic Cardiomyopathy: Unequal Implantable Cardioverter-Defibrillator Use During Hospitalization.
    Patlolla SH; Schaff HV; Nishimura RA; Geske JB; Dunlay SM; Ommen SR
    Mayo Clin Proc; 2022 Mar; 97(3):507-518. PubMed ID: 34893323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival Following Alcohol Septal Ablation or Septal Myectomy for Patients With Obstructive Hypertrophic Cardiomyopathy.
    Cui H; Schaff HV; Wang S; Lahr BD; Rowin EJ; Rastegar H; Hu S; Eleid MF; Dearani JA; Kimmelstiel C; Maron BJ; Nishimura RA; Ommen SR; Maron MS
    J Am Coll Cardiol; 2022 May; 79(17):1647-1655. PubMed ID: 35483751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?
    Lentz Carvalho J; Schaff HV; Nishimura RA; Ommen SR; Geske JB; Lahr BD; Newman DB; Dearani JA
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):79-87.e1. PubMed ID: 33632527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and ethnic disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction.
    Patlolla SH; Shankar A; Sundaragiri PR; Cheungpasitporn W; Doshi RP; Vallabhajosyula S
    Am J Emerg Med; 2022 Jan; 51():202-209. PubMed ID: 34775192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Septal myectomy after failed alcohol ablation: Does previous percutaneous intervention compromise outcomes of myectomy?
    Quintana E; Sabate-Rotes A; Maleszewski JJ; Ommen SR; Nishimura RA; Dearani JA; Schaff HV
    J Thorac Cardiovasc Surg; 2015 Jul; 150(1):159-67.e1. PubMed ID: 25940414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inequities in Treatments and Outcomes Among Patients Hospitalized With Hypertrophic Cardiomyopathy in the United States.
    Johnson DY; Waken RJ; Fox DK; Hammond G; Joynt Maddox KE; Cresci S
    J Am Heart Assoc; 2023 Jun; 12(11):e029930. PubMed ID: 37232238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
    Meghji Z; Nguyen A; Fatima B; Geske JB; Nishimura RA; Ommen SR; Lahr BD; Dearani JA; Schaff HV
    JAMA Cardiol; 2019 Mar; 4(3):237-245. PubMed ID: 30810698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy.
    Solomon Z; Breton C; Rowin EJ; Maron BJ; Maron MS; Chen FY; Rastegar H
    Semin Thorac Cardiovasc Surg; 2018; 30(2):125-128. PubMed ID: 29524602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.
    Leonardi RA; Kransdorf EP; Simel DL; Wang A
    Circ Cardiovasc Interv; 2010 Apr; 3(2):97-104. PubMed ID: 20197511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant Cox-Maze IV and Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy.
    Bakir NH; MacGregor RM; Khiabani AJ; Musharbash FN; Schill MR; Sinn LA; Schuessler RB; Melby SJ; Gleva MJ; Damiano RJ
    Ann Thorac Surg; 2022 Jan; 113(1):109-117. PubMed ID: 33662312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes.
    Firoozi S; Elliott PM; Sharma S; Murday A; Brecker SJ; Hamid MS; Sachdev B; Thaman R; McKenna WJ
    Eur Heart J; 2002 Oct; 23(20):1617-24. PubMed ID: 12323162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Race and Ethnicity With Presentation and Outcomes of Hypertrophic Cardiomyopathy: JACC Focus Seminar 6/9.
    Ntusi NAB; Sliwa K
    J Am Coll Cardiol; 2021 Dec; 78(25):2573-2579. PubMed ID: 34887143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
    Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
    J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term clinical and echocardiographic outcomes of extensive septal myectomy for hypertrophic obstructive cardiomyopathy in Chinese patients.
    Yao L; Li L; Lu XJ; Miao YL; Kang XN; Duan FJ
    Cardiovasc Ultrasound; 2016 May; 14(1):18. PubMed ID: 27189485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.